TITLE:
Management of Malignants Gliomas: About 20 Cases Treated in the Medical Oncology Department of Fattouma Bourguiba University Hospital-Monastir
AUTHORS:
Ben Rejeb Insaf, Sonia Zaied, Hiba Sboui, Amira Daldoul, Nader Slema, Amal Chamsi
KEYWORDS:
Malignant Gliomas, Surgery, Radiotherapy, Chemotherapy, Prognosis
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.12 No.8,
August
25,
2021
ABSTRACT: Introduction: Malignant gliomas refer to grade III or IV brain tumors defined according to the World Health Organization
(WHO) classification. They are a
heterogeneous group of pathologies and represent a serious health problem by their frequency, severity and treatment difficulties. The prognosis
of malignant gliomas remains poor despite all the medical advances. Materials and Methods: It is a retrospective study included 20 cases of
malignant glial tumors treated at the
medical oncology department, Fattouma Bourguiba hospital in Monastir
between 2012 and 2016, according to the STUPP protocol. Results: These
were 12 men and 8 women with a median age of 43. Clinical signs were not very
specific, dominated by intracranial hypertension and deficit signs. Imagery referred to the diagnosis of malignant gliomas in
1st intention. Surgery consisted of a macroscopically complete exeresis
in (15%) cases, a partial exeresis in (50%), the rest of the patients had a
stereotactic biopsy. Histology found GBM in 16 patients (80%), 2 cases of Grade
III anaplastic astrocytoma (10%), 1 case of anaplastic oligodendroglioma (5%),
and 1 case of Grade III anaplastic eppendymoma (5%). Most of our patients
received concurrent radio-chemotherapy and adjuvant TMZ chemotherapy was
administered in 15 patients, 7 of whom received the full 6 scheduled cures. A
relapse treatment was decided in only one of the 12 patients who relapsed. 6
patients are still alive. The median survival is 11.27 months. In our series,
overall survival was related to histological type (p = 0.006) and neurological
status assessed at the end of RT-CT (p = 0.001). While age, general condition
score, type of surgery, and post-therapeutic development did not show a statistically significant
relationship, although survival rates were consistent with the criteria assessed. Conclusion: Malignant gliomas are rare
tumors, bad prognosis, aggravated in Tunisia by a diagnostic
delay. The creation of a multidisciplinary neuro-oncology group can help to
improve management.